Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

59 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Completed

A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease

NCT03099187

Conditions
Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • John Hunter Hospital; Respiratory Department; Respiratory Department New Lambton Heights, New South Wales, Australia
  • Lung Research Queensland Nundah, Queensland, Australia
  • Princess Alexandra Hospital, Department of Respiratory and Sleep Medicine Woolloongabba, Queensland, Australia
View all 66 locations
View Trial Details
Completed

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

NCT02999178

Conditions
Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
View all 153 locations
View Trial Details
Completed

Hepatitis C Virus(HCV) Heart and Lung Study

NCT02858180

Conditions
Blood-Borne Infections, Cardiovascular Diseases, Chronic Disease, +22 more
Locations
  • Henry Ford Health System Detroit, Michigan, United States
  • Columbia University Medical Center New York, United States
  • Duke University Medical Center - Dept of Gastroenterology Durham, North Carolina, United States
  • Harborview Medical Center Seattle, Washington, United States
View Trial Details

Related conditions